Related Experiment Videos
Puerarin blocks Na+ current in rat ventricular myocytes
Guang-Qin Zhang1, Xue-Mei Hao, De-Zai Dai
1Research Division of Pharmacology, China Pharmaceutical University, Nanjing 210009, China.
Acta Pharmacologica Sinica
|December 5, 2003
Summary
Puerarin (Pue) inhibits cardiac sodium channels (INa) in rat heart cells, protecting against damage and arrhythmias by slowing channel recovery. This study reveals its antiarrhythmic potential.
Area of Science:
- Cardiovascular Pharmacology
- Electrophysiology
- Molecular Cardiology
Background:
- Cardiac sodium channels (INa) are crucial for heart electrical activity.
- Dysfunction of INa is implicated in various cardiac arrhythmias and damage.
- Puerarin (Pue) is a natural compound with potential therapeutic properties.
Purpose of the Study:
- To investigate the effects of Puerarin (Pue) on cardiac sodium channels (INa) in rat ventricular myocytes.
- To determine the mechanism by which Pue influences INa function.
Main Methods:
- Whole-cell patch-clamp technique was employed on isolated rat ventricular myocytes.
- Analysis of INa current, I-V curves, and inactivation properties.
Main Results:
- Pue inhibited cardiac INa in a rate- and dose-dependent manner (IC50 = 349 μmol/L).
- Pue significantly shifted the steady-state inactivation curve towards more negative potentials (-15.9 mV).
- Pue prolonged the recovery from INa inactivation (from 21.9 ms to 54.4 ms, P<0.01).
Conclusions:
- Puerarin (Pue) inhibits cardiac INa by significantly affecting its steady-state inactivation.
- The observed effects suggest Pue acts similarly to Class Ia/Ic antiarrhythmic drugs.
- Pue demonstrates protective effects on ventricular myocytes, likely through inhibition of INa recovery, offering potential for treating cardiac damage and arrhythmias.